platelet-rich plasma
-
Biologics
Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE™ PRFM
BIOINCYTE™ is a Next-Generation Autologous Fibrin and Platelet System HACKENSACK, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) — Royal Biologics, a…
Read More » -
Biologics
Royal Biologics announces FDA Approval of the Maxx™ Concentration System.
HACKENSACK, NJ, September 7th, 2021 /OrthoSpineNews/ – Royal Biologics, an ortho-biologics company focused on Autologous and Live Cellular solutions has announced FDA…
Read More » -
Extremities
Blood loss, hospital stay do not decrease with PRP use during TKA
By Monica Jaramillo Patients who underwent total knee arthroplasty with the use of platelet-rich plasma did not experience less blood…
Read More »